Stock Forecast

  Foresight Acquisition Corp. ( FORE) Stock. Should you Buy or Sell?    $ 9.48

0.42 (4.24 %)

Foresight Acquisition Corp. Analysis

Updated on 10-09-2022
Symbol FORE
Price $9.48
Beta 0.000
Volume Avg. $304.62 thousand
Market Cap $382.65 M
52 Week Range $8.85 - $10.17

Foresight Acquisition Corp. opened the day at $9.48 which is +'4.24 % on yesterday's close. Foresight Acquisition Corp. has a 52 week high of $10.17 and 52 week low of $8.85, which is a difference of $1.32. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $382.65 M and total net profit is $0 which means the company is trading at inf times profit to market capitalization. Theoretically, if you were to buy Foresight Acquisition Corp. for $382.65 M, it would take 15 years to get your money back. Foresight Acquisition Corp. are in the Shell Companies space which will have a sweet spot and industry standard for net profit multiples.

Price Chart

1 D | All


Foresight Acquisition Corp. Stock Forecast - Is Foresight Acquisition Corp. a Buy or Sell?

DCF ScoreStrong Buy
ROE ScoreStrong Buy
ROA ScoreSell
DE ScoreSell
PE ScoreSell
PB ScoreStrong Sell
Overall RecommendationNeutral

Growth and Value

PE Ratio -2.057
Dividend Yiel 0.000
Net Profit Margin -0.286

Valuing Foresight Acquisition Corp.

Price Book Value Ratio -8.977 Price To Book Ratio -8.977
Price To Sales Ratio 0.587 Price Earnings Ratio -2.057

How liquid is Foresight Acquisition Corp.

Current Ratio 0.905
Quick Ratio 0.368


Debt Ratio 0.033 Debt Equity Ratio -1.036
Long Term Debt To Capitalization -0.006 Total Debt To Capitalization 0.000

Latest news about Foresight Acquisition Corp.

P3 Health Partners Announces November Conference Schedule and Virtual Investor Day in Advance of Planned Closing of Business Combination with Foresight Acquisition Corp.

NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- P3 Health Partners (“P3”), a patient-centered and physician-led population health management company, which announced earlier this year that it expects to become a public company via a merger with special purpose acquisition company, Foresight Acquisition Corp. (NASDAQ: FORE) (“Foresight”), is scheduled to participate at the following virtual events in November 2021:

Date : 05/11/2021

P3 Health Partners Sets September 2021 Virtual Conference Schedule

NEW YORK, NY / ACCESSWIRE / September 2, 2021 / P3 Health Partners ("P3"), a patient-centered and physician-led population health management company, which recently announced its business combination with Foresight Acquisition Corp. (NASDAQ:FORE), a publicly traded special purpose acquisition company, is scheduled to participate at the following virtual financial conferences in September 2021: 10 th Annual Gateway Conference Presentation: Thursday, September 9th at 11:30am Eastern time Webcast: Link Wells Fargo Virtual Healthcare Conference Presentation: Friday, September 10th at 11:20am Eastern time Webcast: Link To receive additional information, request an invitation or to schedule a one-on-one meeting, please contact your Wells Fargo representative or the Company's investor relations team at About P3 Health Partners P3 is a patient-centered and physician-led population health management company.

Date : 02/09/2021

Moore Kuehn Encourages FMBI, LWAC, LEGO and FORE Investors to Contact Law Firm

NEW YORK, June 21, 2021 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: First Midwest Bancorp, Inc. (NASDAQ: FMBI) First Midwest has agreed to merge with Old National Bancorp.

Date : 21/06/2021

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Foresight Acquisition Corp. - FORE

NEW YORK, June 5, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Foresight Acquisition Corp. ("FORE" or the "Company") ( FORE ) relating to its proposed merger with P3 Health Partners. Under the terms of the agreement, FORE will acquire P3 through a reverse-merger, with P3 emerging as a publicly traded company.

Date : 05/06/2021

About Foresight Acquisition Corp.

CEO : Mr. Michael P. Balkin
Sector : Financial Services
Industry : Shell Companies

Website :

Exchange : Nasdaq Global Select

Description :

Foresight Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was founded in 2020 and is based in Chicago, Illinois.

My Newsletter

Sign Up For Updates & Newsletters